Journal
CURRENT MEDICINAL CHEMISTRY
Volume 16, Issue 11, Pages 1391-1399Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986709787846550
Keywords
Nucleoside analogs; oral absorption; prodrug
Ask authors/readers for more resources
Nucleoside analogs are first line chemotherapy in various severe diseases: AIDS (acquired immunodeficiency disease syndrome), cytomegalovirus infections, cancer etc. However, most of these compounds suffer from poor bioavailability via oral route. In order to get around this drawback, researchers have imagined many strategies including drug metabolism inhibitors, bio adhesive nanoparticles, amino ester prodrugs, as well as enhancing absorption by increasing drug lipophilicity. This paper illustrated these approaches by developing their application to some nucleoside analogs. Moreover, some of these strategies were very successful and some resulting compounds are now approved by FDA (Food and Drug Administration).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available